Search
Compendia
Normalized Compendia
RNA-seq Sample Compendia
Docs
About
My Dataset
Back to Top
GSE23206
NSCLC cells treated with Gefitinib
Add to Dataset
Homo sapiens
2 Downloadable Samples
Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)
Submitter Supplied Information
Description
About 10% of all NSCLC patients respond to gefitnib treatment and all of these patients will acquire resistance to the EGFR TKI.
PubMed ID
21152424
Publication Title
Rapidly acquired resistance to EGFR tyrosine kinase inhibitors in NSCLC cell lines through de-repression of FGFR2 and FGFR3 expression.
Total Samples
2
Submitter’s Institution
University of Colorado Denver
Authors
Ware KE
,
Marshall ME
,
Heasley LR
,
Marek L
,
Hinz TK
,
Hercule P
,
Helfrich BA
,
Doebele RC
,
Heasley LE
Source Repository
Gene Expression Omnibus (GEO)
Samples
Add to Dataset
Show
10
of 0 Total Samples
Show only samples in current dataset
Filter
Expand Table
Add/Remove
Accession Code
Title
Cell line
Treatment
Processing Information
Additional Metadata
No rows found
Loading...